Equities analysts expect Globus Medical, Inc. (NYSE:GMED) to report sales of $235.53 million for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Globus Medical’s earnings. The highest sales estimate is $243.24 million and the lowest is $230.81 million. Globus Medical posted sales of $227.34 million in the same quarter last year, which suggests a positive year over year growth rate of 3.6%. The business is expected to issue its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Globus Medical will report full-year sales of $1.03 billion for the current fiscal year, with estimates ranging from $1.03 billion to $1.04 billion. For the next year, analysts expect that the firm will post sales of $1.14 billion, with estimates ranging from $1.11 billion to $1.16 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Globus Medical.
Globus Medical (NYSE:GMED) last released its quarterly earnings data on Thursday, February 17th. The medical device company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01. Globus Medical had a return on equity of 12.69% and a net margin of 15.57%. During the same period in the prior year, the company posted $0.58 EPS.
Equities analysts expect Globus Medical, Inc. (NYSE:GMED) to report sales of $235.53 million for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Globus Medical’s earnings. The highest sales estimate is $243.24 million and the lowest is $230.81 million. Globus Medical posted sales of $227.34 million in the same quarter last year, which suggests a positive year over year growth rate of 3.6%. The business is expected to issue its next quarterly earnings report on Monday, January 1st.
According to Zacks, analysts expect that Globus Medical will report full-year sales of $1.03 billion for the current fiscal year, with estimates ranging from $1.03 billion to $1.04 billion. For the next year, analysts expect that the firm will post sales of $1.14 billion, with estimates ranging from $1.11 billion to $1.16 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Globus Medical.
Globus Medical (NYSE:GMED) last released its quarterly earnings data on Thursday, February 17th. The medical device company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01. Globus Medical had a return on equity of 12.69% and a net margin of 15.57%. During the same period in the prior year, the company posted $0.58 EPS.
SOURCE: https://www.marketbeat.com